TickerFacts.

Company research / YDES

YD Bio Ltd (YDES)

Also trades as YDESW. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

CIK 0002011674 · Nasdaq · Services-Medical Laboratories

  • Sector Services
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, YD Bio Ltd reported revenue of $596.8K. Revenue grew 16.9% from the prior annual period.

Key ratios (year ended 2025-12-31)

28.1%
Gross margin
-883.3%
Operating margin
n/m
Net margin
16.9%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-06

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-31
Revenue$596.8K$510.4K$350.1K
Cost of Revenue$429.4K$355.0K$196.7K
Gross Profit$167.4K$155.4K$153.4K
R&D Expense$1.60M$491.4Kn/a
Operating Income-$5.27M-$1.46M-$9.8K
Net Income-$8.31M-$1.41M$13.6K
EPS (Diluted)-$0.12-$0.02$0.00
Total Assets$13.78M$6.86Mn/a
Total Liabilities$16.64M$274.0Kn/a
Shareholders' Equity-$2.86M$6.59M$23.0K
Cash & Equivalents$6.01M$3.13Mn/a
Operating Cash Flow-$6.60M-$1.22M-$55.7K
Capital Expenditures$1.44M$74.9K$290
Free Cash Flow-$8.04M-$1.30M-$55.9K
Shares Outstanding70.79M64.73Mn/a
Weighted Average Diluted Shares66.72M64.73M64.73M
EPS (Basic)-$0.12-$0.02$0.00

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView